N-Acetylcysteine—a safe antidote for cysteine/glutathione deficiency
Top Cited Papers
- 1 August 2007
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 7 (4) , 355-359
- https://doi.org/10.1016/j.coph.2007.04.005
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- N-Acetylcysteine and contrast-induced nephropathy: A meta-analysis of 13 randomized trialsAmerican Heart Journal, 2006
- N‐acetylcysteine – passe‐partout or much ado about nothing?British Journal of Clinical Pharmacology, 2005
- Oral or Intravenous N-Acetylcysteine for Acetaminophen Poisoning?Annals of Emergency Medicine, 2005
- Genetic and Metabolic Control of the Mitochondrial Transmembrane Potential and Reactive Oxygen Intermediate Production in HIV DiseaseAntioxidants and Redox Signaling, 2000
- COST-EFFECTIVENESS ANALYSIS OF ORAL N -ACETYLCYSTEINE AS A PREVENTIVE TREATMENT IN CHRONIC BRONCHITISPharmacological Research, 2000
- Population, Acid−Base, and Redox Properties ofN-Acetylcysteine ConformersJournal of Medicinal Chemistry, 2000
- HIV-induced cysteine deficiency and T-cell dysfunction — a rationale for treatment with N-acetylcysteineImmunology Today, 1992
- Clinical Pharmacokinetics of N-AcetylcysteineClinical Pharmacokinetics, 1991
- N-Acetylcysteine Modifies the Acute Effects of Isosorbide-5-Mononitrate in Angina Pectoris Patients Evaluated by Exercise TestingJournal of Cardiovascular Pharmacology, 1989
- Oral fabrol (oral N-acetylcysteine) in chronic bronchitisRespiratory Medicine, 1987